Trade Vir Biotechnology VIR

VirBiotechnology live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jun 05, 03:55

Vir Biotechnology (NASDAQ:VIR) Director Sells $30,240.00 in Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jun 05, 00:12

Reviewing Beam Therapeutics (NASDAQ:BEAM) & Vir Biotechnology (NASDAQ:VIR) - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jun 04, 00:20

Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Vir Biotechnology (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 03, 15:00

VIR Maintained by Leerink Partners -- Price Target Raised to $21

Vir Biotechnology Inc
Webhose 2026 Jun 03, 14:41

Vir Biotechnology (NASDAQ:VIR) Price Target Raised to $21.00

Vir Biotechnology Inc
Webhose 2026 Jun 03, 07:41

Leerink Partners Forecasts Strong Price Appreciation for Vir Biotechnology (NASDAQ:VIR) Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jun 03, 01:09

Insider Sell: Brent Sabatini Sells Shares of Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 03, 01:09

Insider Sell: Janet Napolitano Sells 3,200 Shares of Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 02, 00:00

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology Inc
Webhose 2026 May 28, 08:13

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Average Rating of "Moderate Buy" from Analysts

Vir Biotechnology Inc
Webhose 2026 May 28, 08:09

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Analysts

Vir Biotechnology Inc
Webhose 2026 May 27, 11:07

UBS Group AG Purchases 203,203 Shares of Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc
Webhose 2026 May 25, 00:20

Assessing Vir Biotechnology (VIR) Valuation After Hepatitis Delta Data Update And Astellas Oncology Partnership

Vir Biotechnology Inc
Webhose 2026 May 18, 21:30

VIR: Vir Biotechnology Prepares to Present Trial Data at EASL Congress 2026

Vir Biotechnology Inc
Webhose 2026 May 18, 15:19

Vir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 Million

Vir Biotechnology Inc
Webhose 2026 May 15, 10:49

Vanguard Group Inc. Reduces Stock Position in Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc
Webhose 2026 May 13, 06:00

Vir Biotechnology Inc at Bank of America Global Healthcare Conference Transcript

Vir Biotechnology Inc
Webhose 2026 May 12, 07:40

Q2 EPS Estimates for Vir Biotechnology Cut by HC Wainwright - Stock Observer

Vir Biotechnology Inc
Webhose 2026 May 11, 15:03

Vir Biotechnology, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next - Simply Wall St News

Vir Biotechnology Inc
Webhose 2026 May 10, 07:15

Vir Biotechnology (NASDAQ:VIR) Downgraded by Wall Street Zen to Sell - Stock Observer

Vir Biotechnology Inc
Webhose 2026 May 10, 03:13

A Look At Vir Biotechnology (VIR) Valuation After The Astellas Partnership And Pipeline Progress

Vir Biotechnology Inc
Webhose 2026 May 09, 05:35

Vir Biotechnology (NASDAQ:VIR) Downgraded to "Sell" Rating by Wall Street Zen

Vir Biotechnology Inc
Webhose 2026 May 07, 09:14

Vir Biotechnology (NASDAQ:VIR) Releases Quarterly Earnings Results, Misses Expectations By $0.84 EPS - Stock Observer

Vir Biotechnology Inc
Webhose 2026 May 07, 08:18

Vir Biotechnology Q1 Earnings Call Highlights

Vir Biotechnology Inc
Webhose 2026 May 07, 05:44

Insider Selling: Vir Biotechnology (NASDAQ:VIR) Director Sells $221,100.00 in Stock - Stock Observer

Vir Biotechnology Inc

VirBiotechnology News

Emma Rose 2026 Jun 06, 00:00

US Monetary Policy Pivot: Non-Farm Payrolls, Inflation Fears, and Potential Rate Hikes

Sophia Claire 2026 Jun 06, 00:00

Netanyahu-Trump Rift Exposed: Ceasefire Talks Put Israeli Election Stakes in Jeopardy

Liam James 2026 Jun 06, 00:00

US May Jobs Report: A Critical Indicator for the Fed's Interest Rate Path

Liam James 2026 Jun 06, 00:00

AI Bubble Risks and Market Correction: Insights from TS Lombard

Ava Grace 2026 Jun 06, 00:00

Global Market Indicators and Trading Strategy Updates: June 5, 2026

Ghko B 2026 Jun 02, 16:01

Regulated CFD Brokers in UAE: IG, Pepperstone, FOREX.com, markets.com

cfd trading
Frances Wang 2026 Jun 02, 16:01

UAE Economy Overview 2026: GDP Growth Driven by Non-Oil Sectors

Ghko B 2026 Jun 02, 16:01

Regulated CFD Brokers in South Africa: Capital.com, XTB, Pepperstone, markets.com

cfd trading
Ghko B 2026 May 31, 16:01

Will gold hit $6000 in 2026: How to invest in gold in South Africa?

commodity
Ghko B 2026 May 31, 16:01

Will gold hit $6000 in 2026: How to invest in gold in UAE?

commodity

Latest news

Show more
Noah Lee 2026 Jun 06, 00:00

Market Pulse: Dollar Rises, Gold Dips Post-US Jobs Data; Geopolitical Tensions Simmer

Sophia Claire 2026 Jun 06, 00:00

US May Jobs Report Signals Slowing Growth: A Deep Dive into Market Indicators

Sophia Claire 2026 Jun 06, 00:00

Hormuz Strait Oil Tanker Activity Shifts: Increased Secrecy and Market Fragmentation

Emma Rose 2026 Jun 06, 00:00

US May Jobs Report Exceeds Expectations, Bolstering Economic Resilience and Shifting Fed Rate Outlook

Sophia Claire 2026 Jun 06, 00:00

Hormuz Strait Shipping Resumes Amid Gulf Tensions and US Coordination

Emma Rose 2026 Jun 06, 00:00

Strong US Jobs Report Fuels Inflation Concerns, Dampens Rate Cut Hopes

Ava Grace 2026 Jun 06, 00:00

US Energy Shift Reshapes Inflation Dynamics and Fed Policy Outlook

Liam James 2026 Jun 06, 00:00

Iran's Nuclear Verification Faces Restrictions Amidst Escalating Tensions, IAEA Report Highlights

Info

Spread

0.07

Spread (%)

0.8121 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1543165440

Shares Outstanding

168651974

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.13

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
forex-pattern
Julian Parker 2026 Jun 04, 16:03

Top 15 Forex Chart Patterns You Need to Know

Julian Parker 2026 Jun 04, 16:02

3-5-7 Rule in Trading: How It Works, Examples and Risks

Julian Parker 2026 Jun 04, 16:01

What Is a Protective Put? Strategy, Cost & When to Use It

Trustpilot